Home > Income Statement > VALIANT LABORATORIES

VALIANT LABORATORIES
Revenue

    Back to Income Statement
VALIANT LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Sales ₹237 Cr₹133 Cr₹182 Cr₹334 Cr

What is the latest Revenue of VALIANT LABORATORIES ?

The latest Revenue ratio of VALIANT LABORATORIES is ₹237 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹237 Cr
Mar2025₹133 Cr
Mar2024₹182 Cr
Mar2023₹334 Cr

How is Revenue of VALIANT LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹237 Cr
78.04
Mar2025 ₹133 Cr
-26.74
Mar2024 ₹182 Cr
-45.48
Mar2023 ₹334 Cr -

Compare Revenue of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹694.5 Cr 1% 4.9% 52.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

1%

4.9%

52.3%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses